Literature DB >> 2019356

Presence of PAF-acether in stool of patients with pouch ileoanal anastomosis and pouchitis.

S Chaussade1, Y Denizot, P Valleur, J Nicoli, P Raibaud, J Guerre, P Hautefeuille, D Couturier, J Benveniste.   

Abstract

Platelet-activating factor is an endogenous phospholipid produced by a wide variety of inflammatory cells. Platelet-activating factor induces severe pathological changes in various organs and, among numerous potent effects, causes bowel necrosis. Pouchitis is a poorly understood complication of ileoanal pouch anastomosis which occurs in patients who undergo surgery for ulcerative colitis. The aim of this study was to measure ileal or fecal platelet-activating factor and lyso platelet-activating factor contents in normal volunteers (n = 12), in patients with terminal ileostomy (n = 7), and in patients with ileoanal anastomosis (n = 15) (8 patients have pouchitis defined by the presence of ulcerations on the reservoir). Fecal samples were processed and assessed for platelet-activating factor by platelet aggregation assay. The aggregating material was further characterized as platelet-activating factor by the following: inhibition of the platelet aggregation it induced by specific platelet-activating factor receptor antagonist (BN 52021; IHB, Le Plessis Robinson, France); abolition of platelet aggregation after incubation with phospholipase A2 but not with lipase A1; and retention time on high-performance liquid chromatography. Stool platelet-activating factor content (in nanograms per gram of stool, mean +/- 1SD) was significantly increased in patients with pouchitis (22.2 +/- 16 ng/g) compared with patients with normal reservoir (1.59 +/- 0.63 ng/g, P less than 0.01), terminal ileostomy (0.59 +/- 0.43 ng/g, P less than 0.01), and healthy controls (0 +/- 0 ng/g of stool, P less than 0.001). Lyso platelet-activating factor (nanograms per gram of stool) was increased in patients with pouchitis (10,704 +/- 5499 ng/g) compared with patients with normal reservoir (4721 +/- 4549 ng/g of stool, P less than 0.05), terminal ileostomy (3042 +/- 4019 ng/g, P less than 0.02), and healthy volunteers (128 +/- 107 ng/g, P less than 0.001). In patients with ileoanal anastomosis and pouchitis, increased platelet-activating factor production could be implicated in the inflammation and ulcerations observed in the reservoir.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2019356     DOI: 10.1016/0016-5085(91)90646-3

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  14 in total

Review 1.  Acute and chronic pouchitis--pathogenesis, diagnosis and treatment.

Authors:  Bo Shen
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-04-17       Impact factor: 46.802

2.  Quantification of distinct molecular species of platelet activating factor in ulcerative colitis.

Authors:  E Thyssen; J Turk; A Bohrer; W F Stenson
Journal:  Lipids       Date:  1996-03       Impact factor: 1.880

3.  Preoperative terminal ileal and colonic resection histopathology predicts risk of pouchitis in patients after ileoanal pull-through procedure.

Authors:  C M Schmidt; A J Lazenby; R J Hendrickson; J V Sitzmann
Journal:  Ann Surg       Date:  1998-05       Impact factor: 12.969

4.  Intestinal epithelial cells contribute to the enhanced generation of platelet activating factor in ulcerative colitis.

Authors:  L Ferraris; F Karmeli; R Eliakim; J Klein; C Fiocchi; D Rachmilewitz
Journal:  Gut       Date:  1993-05       Impact factor: 23.059

Review 5.  Pouchitis: a spectrum of diseases.

Authors:  Bo Shen; Bret A Lashner
Journal:  Curr Gastroenterol Rep       Date:  2005-10

6.  Secondary pouchitis in a post-operative patient with ulcerative colitis, successfully treated by salvage surgery.

Authors:  Yuji Toiyama; Toshimitsu Araki; Shigeyuki Yoshiyama; Chikao Miki; Masato Kusunoki
Journal:  World J Gastroenterol       Date:  2005-11-21       Impact factor: 5.742

7.  Diagnosis and treatment of pouchitis.

Authors:  Bo Shen; Bret A Lashner
Journal:  Gastroenterol Hepatol (N Y)       Date:  2008-05

8.  Treatment of Crohn's disease recurrence after ileoanal anastomosis by azathioprine.

Authors:  W Berrebi; S Chaussade; A L Bruhl; A Pariente; P Valleur; P Hautefeuille; D Couturier
Journal:  Dig Dis Sci       Date:  1993-08       Impact factor: 3.199

9.  PAF-acether and acetylhydrolase in stool of patients with Crohn's disease.

Authors:  Y Denizot; S Chaussade; N Nathan; J F Colombel; M J Bossant; N Cherouki; J Benveniste; D Couturier
Journal:  Dig Dis Sci       Date:  1992-03       Impact factor: 3.199

Review 10.  Pouchitis.

Authors:  En-Da Yu; Zhuo Shao; Bo Shen
Journal:  World J Gastroenterol       Date:  2007-11-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.